A method for determination of the absolute pulmonary bioavailability of inhaled drugs: terbutaline - PubMed (original) (raw)

A method for determination of the absolute pulmonary bioavailability of inhaled drugs: terbutaline

L Borgström et al. Pharm Res. 1990 Oct.

Abstract

Terbutaline sulfate (4 X 0.250 mg) was given to 11 healthy volunteers by inhalation from a metered dose inhaler (MDI), with and without oral administration of a charcoal slurry. Before the inhalations, the adsorbing capacity of the charcoal slurry was tested. Deuterated terbutaline, 0.125 mg, was given intravenously at the same time as the test doses. The charcoal slurry adsorbed 97% of an oral dose. The oral contribution to the overall systemic bioavailability after inhalation, when charcoal was coadministered, could thus be neglected. After inhalation of terbutaline, 9.1% of the dose was deposited in the lungs and an additional 6.7% was systemically available via the oral route. The method presented measures the absolute pulmonary bioavailability after inhalation from a MDI. Since a deuterated analogue is given intravenously together with the inhalations, fewer subjects are needed to obtain reliable data.

PubMed Disclaimer

Similar articles

• Relative bioavailability of terbutaline to the lung following inhalation, using urinary excretion.
  Abdelrahim ME, Assi KH, Chrystyn H. Abdelrahim ME, et al. Br J Clin Pharmacol. 2011 Apr;71(4):608-10. doi: 10.1111/j.1365-2125.2010.03873.x. Br J Clin Pharmacol. 2011. PMID: 21395654 Free PMC article.
• Comparison of gamma scintigraphy and a pharmacokinetic technique for assessing pulmonary deposition of terbutaline sulphate delivered by pressurized metered dose inhaler.
  Newman S, Steed K, Hooper G, Källén A, Borgström L. Newman S, et al. Pharm Res. 1995 Feb;12(2):231-6. doi: 10.1023/a:1016278926231. Pharm Res. 1995. PMID: 7784338 Clinical Trial.
• Emitted dose and lung deposition of inhaled terbutaline from Turbuhaler at different conditions.
  Abdelrahim ME. Abdelrahim ME. Respir Med. 2010 May;104(5):682-9. doi: 10.1016/j.rmed.2009.11.014. Epub 2009 Dec 8. Respir Med. 2010. PMID: 20004090
• Pharmacokinetics of inhaled drugs.
  Lipworth BJ. Lipworth BJ. Br J Clin Pharmacol. 1996 Dec;42(6):697-705. doi: 10.1046/j.1365-2125.1996.00493.x. Br J Clin Pharmacol. 1996. PMID: 8971424 Free PMC article. Review.
• Determination of lung deposition following inhalation of ciclesonide using different bioanalytical procedures.
  Nave R. Nave R. Bioanalysis. 2010 Apr;2(4):807-14. doi: 10.4155/bio.10.21. Bioanalysis. 2010. PMID: 21083275 Review.

Cited by

• Relative bioavailability of terbutaline to the lung following inhalation, using urinary excretion.
  Abdelrahim ME, Assi KH, Chrystyn H. Abdelrahim ME, et al. Br J Clin Pharmacol. 2011 Apr;71(4):608-10. doi: 10.1111/j.1365-2125.2010.03873.x. Br J Clin Pharmacol. 2011. PMID: 21395654 Free PMC article.
• Inferring pulmonary exposure based on clinical PK data: accuracy and precision of model-based deconvolution methods.
  Himstedt A, Borghardt JM, Wicha SG. Himstedt A, et al. J Pharmacokinet Pharmacodyn. 2022 Apr;49(2):135-149. doi: 10.1007/s10928-021-09780-x. Epub 2021 Sep 28. J Pharmacokinet Pharmacodyn. 2022. PMID: 34585333 Free PMC article.
• Determination of the relative bioavailability of salbutamol to the lung following inhalation.
  Hindle M, Chrystyn H. Hindle M, et al. Br J Clin Pharmacol. 1992 Oct;34(4):311-5. doi: 10.1111/j.1365-2125.1992.tb05921.x. Br J Clin Pharmacol. 1992. PMID: 1457264 Free PMC article. Clinical Trial.
• Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.
  Hindle M, Newton DA, Chrystyn H. Hindle M, et al. Thorax. 1993 Jun;48(6):607-10. doi: 10.1136/thx.48.6.607. Thorax. 1993. PMID: 8346489 Free PMC article.
• Pharmacokinetic optimisation of asthma treatment.
  Taburet AM, Schmit B. Taburet AM, et al. Clin Pharmacokinet. 1994 May;26(5):396-418. doi: 10.2165/00003088-199426050-00006. Clin Pharmacokinet. 1994. PMID: 7914480 Review.

References

1. 1. Clin Pharmacokinet. 1982 Nov-Dec;7(6):490-507 - PubMed
2. 1. Postgrad Med J. 1975;51(7 SUPPL):69-75 - PubMed
3. 1. J Pharm Sci. 1988 Nov;77(11):952-4 - PubMed
4. 1. Xenobiotica. 1973 Dec;3(12):787-99 - PubMed
5. 1. Eur J Respir Dis Suppl. 1984;134:149-60 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.